Antidepressant medications and osteoporosis

Antidepressant medications and osteoporosis

Use of antidepressant medications that act on the serotonin system has been linked to detrimental impacts on bone mineral density (BMD), and to osteoporosis. This article reviews current evidence for such effects, and identifies themes for future research. Serotonin receptors are found in all major...

Detaylı Bibliyografya
Asıl Yazarlar:	Rizzoli, R, Cooper, C, Reginster, J, Abrahamsen, B, Adachi, J, Brandi, M, Bruyère, O, Compston, J, Ducy, P, Ferrari, S, Harvey, N, Kanis, J, Karsenty, G, Laslop, A, Rabenda, V, Vestergaard, P
Materyal Türü:	Journal article
Baskı/Yayın Bilgisi:	2012

Benzer Materyaller

Partial adherence: a new perspective on health economic assessment in osteoporosis.
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

A reappraisal of generic bisphosphonates in osteoporosis.
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Management of glucocorticoid-induced osteoporosis.
Yazar:: Rizzoli, R, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
Yazar:: Rizzoli, R, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation.
Yazar:: Delmas, P, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (Osteoporosis International DOI: 10.1007/s00198-008-0560-z)
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Health technology assessment in osteoporosis.
Yazar:: Hiligsmann, M, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

The International Osteoporosis Foundation: history, objectives and achievements.
Yazar:: Cooper, C, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

The International Osteoporosis Foundation: History, objectives and achievements
Yazar:: Cooper, C, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).
Yazar:: Cooper, C, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (vol 19, pg 399, 2008)
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
Yazar:: Rizzoli, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
Yazar:: Rizzoli, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Management of osteoporosis of the oldest old (vol 25, pg 2507, 2014)
Yazar:: Rizzoli, R, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
Yazar:: Bruyère, O, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Challenges for the development of bone-forming agents in Europe
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Challenges for the development of bone-forming agents in Europe.
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

The role of calcium supplementation in healthy musculoskeletal ageing : An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF).
Yazar:: Harvey, N, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.
Yazar:: Rizzoli, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Treatment of osteoporosis in men.
Yazar:: Kaufman, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Modelling cost-effectiveness in osteoporosis
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
Yazar:: Rizzoli, R, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

DEVELOPMENT AND VALIDATION OF A DISEASE MODEL FOR POSTMENOPAUSAL OSTEOPOROSIS
Yazar:: Gauthier, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

The cost-effectiveness of alendronate in the management of osteoporosis.
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Assessment of cardiovascular safety of anti-osteoporosis drugs
Yazar:: Fuggle, NR, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
Yazar:: Hiligsmann, M, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Changes in structure and symptoms in knee osteoarthritis and prediction of future knee replacement over 8 years.
Yazar:: Bruyere, O, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

CHANGES IN THE STRUCTURE AND THE SYMPTOMS OF THE OSTEOARTHRITIC KNEE AND PREDICTION OF FUTURE KNEE REPLACEMENT OVER AN 8-YEAR FOLLOW-UP PERIOD
Yazar:: Bruyere, O, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013.
Yazar:: Compston, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Radiofrequency echographic multi spectrometry (REMS) in the diagnosis and management of osteoporosis: state of the art
Yazar:: Fuggle, NR, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Development and validation of a disease model for postmenopausal osteoporosis.
Yazar:: Gauthier, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Fracture risk following intermission of osteoporosis therapy
Yazar:: Dennison, EM, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.
Yazar:: Kanis, J, ve diğerleri
Baskı/Yayın Bilgisi: (1997)

Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
Yazar:: Bruyère, O, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).
Yazar:: Ström, O, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

DEVELOPMENT AND VALIDATION OF AN EPIDEMIOLOGICAL MODEL TO ESTIMATE THE BURDEN OF POST-MENOPAUSAL OSTEOPOROSIS
Yazar:: Gauthier, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 (vol 75, pg 392, 2013)
Yazar:: Compston, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Erratum: Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 (Maturitas (2013) 75 (392-396))
Yazar:: Compston, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)